Purchase Order HHSN272201701000P
Award Date
8/17/17
Potential Completion Date
9/8/17
Potential Value
$6.7K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Stemcell Technologies Inc.
Ultimate Awardee
Not listed
PSC Category
6509 - Drugs And Biologicals, Veterinary Use
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Seattle, WA 98168, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $8,616.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a Canadian biotechnology company. The contract is for the provision of EasySep Negative Human CD4 Kits, which are specialized cell separation products used to support biomedical research initiatives, particularly in the areas of stem cell research, immunology, cancer...
This federal contract award, valued at $22,786.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Stemcell Technologies Inc., a Canadian biotechnology company. The contract is for the delivery of the EasySep Negative Human CD4 Kit, a specialized cell isolation product used to support biomedical research initiatives, particularly in the areas of immunology, infectious disease, and stem cell studies. The...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a Canadian biotechnology company. The contract, valued at $5,636.00, is for the delivery of EasySep Negative Human CD4 Kits, which are specialized cell isolation products used to support biomedical research. Stemcell Technologies Inc....
This $9,759 federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a Canadian biotechnology company. The contract is for the provision of "Negative Human CD4 Kits", which are likely specialized biological materials and cell isolation kits to support biomedical research on infectious diseases....
The National Institute of Allergy and Infectious Diseases (NIAID), a sub-agency of the U.S. Department of Health and Human Services (HHS), awarded a $80,536.00 firm-fixed-price purchase order contract to Stemcell Technologies Inc. for EasySep Negative Human CD4 and CD8 Kits. This contract does not have a set-aside designation. Stemcell Technologies Inc. is a Canadian biotechnology company that specializes in cell culture media, cell separation systems, and other life sciences research...
This is a federal contract award to Stemcell Technologies Inc., a Canadian biotechnology company, for the supply of an EasySep Negative Human CD4 Kit, catalog number 19052. The award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The contract has a ceiling value of $39,906.40 and is structured as a firm fixed price purchase order. The contract is...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $12,670.00 firm fixed price purchase order to Stemcell Technologies Inc., a Canadian-owned for-profit company, for CD4 EASYSEP NEGATIVE SELECTION KITS. This award was not set aside for any particular business type. Stemcell Technologies Inc. is an experienced federal contractor that frequently provides specialized biological materials, lab supplies, scientific...
This federal contract award to Stemcell Technologies Inc., a Canadian biotechnology company, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a sub-agency of the U.S. Department of Health and Human Services (HHS). The $24,536.00 firm fixed-price purchase order is for the provision of the AMBIS 1787964 QUOTE Q-921198 item, which is described as the "EASY STEP NEGATIVE HUMAN CD4 KIT". The award does not have a small business set-aside designation. Stemcell...
This is a $17,134.00 firm fixed price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Stemcell Technologies Inc., a Canadian biotechnology company. The contract is for the supply of EasySep Negative Human CD4 Kits, which are used in cell separation and cell culture applications to support biomedical research. The contract is a Blanket Purchase Agreement (BPA) call, meaning it is part of a larger indefinite...
This federal contract award was made by the National Institutes of Health (NIH) to Stemcell Technologies Inc., a Canadian biotechnology company that specializes in cell culture media, cell separation systems, and other life sciences research products. The contract, which is a Blanket Purchase Agreement (BPA) with a ceiling value of $10,000,000, authorizes Stemcell Technologies Inc. to provide a comprehensive range of biological materials, blood and blood products, laboratory supplies, media, and...